28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 6200 - 6400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1028 | Procedures for Sexual Activity | active | 2024-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1030 | Procedures for Sexual Activity | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1031 | Diagnosis for Sexual Activity | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1032 | Diagnosis for Sexual Activity | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1033 | Procedures for Sexual Activity | active | 2021-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1007 | Lab Tests During Pregnancy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1008 | Diagnostic Studies During Pregnancy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1011 | Pregnancy Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1012 | Complications of Pregnancy, Childbirth and the Puerperium | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1016 | Congenital or Acquired Absence of Cervix | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1017 | Procedures Used to Indicate Sexual Activity | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1018 | Diagnoses Used to Indicate Sexual Activity | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.112.11.1024 | Absence of Cervix | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.112.11.1025 | Absence of Cervix | active | 2021-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.112.11.1026 | Absence of Cervix | active | 2023-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1073 | Osteoporosis Without Current Fracture | active | 2017-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1074 | Osteoporosis Without Current Fracture | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1200 | Osteoporosis With Current Fracture | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1201 | Osteoporosis With Current Fracture | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1202 | DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine | active | 2021-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1308 | Frailty Diagnosis | active | 2024-11 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1309 | Frailty Diagnosis | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1310 | Frailty Symptom | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1311 | Frailty Symptom | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1038 | Osteoporosis Without Current Fracture | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1050 | Osteoporosis With Current Fracture | active | 2018-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1051 | DXA (Dual energy Xray Absorptiometry) Scan | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1074 | Frailty Diagnosis | active | 2019-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1075 | Frailty Symptom | active | 2019-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1021 | Narcolepsy | active | 2018-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1023 | Narcolepsy | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1024 | Neurologic impairment | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1025 | Neurologic impairment | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1026 | Neurologic impairment | active | 2021-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.12.1011 | Narcolepsy | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.12.1012 | Neurologic impairment | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1149 | Substance Use Disorder Long Acting Medication | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.115.11.1248 | Retinal or Dilated Eye Exam | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.115.12.1088 | Retinal or Dilated Eye Exam | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1150 | Substance Use Disorder Short Acting Medication | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1151 | Substance Use Disorder Long Acting Medication Administration | active | 2025-01 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1152 | Substance Use Disorder Short Acting Medication Administration | active | 2024-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1155 | Substance Use Disorder Short Acting Medication Administration | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1156 | Substance Use Disorder Long Acting Medication Administration | active | 2021-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1157 | Substance Use Disorder Short Acting Medication Administration | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1163 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1164 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1165 | Hospice Diagnosis | active | 2022-08 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1166 | Hospice Diagnosis | active | 2022-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1167 | Palliative Care Diagnosis | active | 2022-08 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1168 | Palliative Care Diagnosis | active | 2022-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1169 | Palliative Care Diagnosis | active | 2022-08 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.117.11.1031 | Hyperthyroidism | active | 2018-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.117.11.1033 | Hyperthyroidism | active | 2018-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.117.11.1034 | Hyperparathyroidism | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.117.11.1036 | Hyperparathyroidism | active | 2018-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.117.12.1015 | Hyperthyroidism | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.117.12.1016 | Hyperparathyroidism | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1170 | Atomoxetine | active | 2022-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1171 | Clonidine | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1172 | Dexmethylphenidate | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1173 | Dextroamphetamine | active | 2022-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1174 | Lisdexamfetamine | active | 2022-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1176 | Methylphenidate | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1177 | Lower Body Fractures Excluding Ankle and Foot | active | 2022-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1178 | Lower Body Fractures Excluding Ankle and Foot | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1179 | Malignant Neoplasms of Lower and Unspecified Limbs | active | 2022-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.11.1042 | Counseling for Physical Activity | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.11.1077 | Falls Screening | active | 2018-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.11.1097 | CT Colonography | active | 2019-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.11.1220 | Frailty Device SNOMED | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.12.1028 | Falls Screening | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.12.1035 | Counseling for Physical Activity | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.118.12.1300 | Frailty Device | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1180 | Malignant Neoplasms of Lower and Unspecified Limbs | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1181 | Mechanical Complications Excluding Upper Body | active | 2022-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1182 | Mechanical Complications Excluding Upper Body | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1183 | Partial Arthroplasty of Hip | active | 2022-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1184 | Partial Arthroplasty of Hip | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1188 | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | 2022-12 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1189 | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1190 | Antibiotic Medications for Upper Respiratory Infection | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1193 | Malignant Neoplasms | active | 2022-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1194 | Malignant Neoplasms | active | 2022-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1196 | Atherosclerosis of the Extremities | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1197 | Atherosclerosis of the Extremities | active | 2023-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1198 | Atherosclerosis of the Extremities | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1199 | Lower Extremity Neurological Assessment Result or Finding | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1001 | Disorders of the Immune System | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1003 | Disorders of the Immune System | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1004 | HIV Viral Load | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1008 | HIV 2 | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1010 | HIV 2 | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1011 | Severe Combined Immunodeficiency | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.11.1012 | Severe Combined Immunodeficiency | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.12.1001 | Disorders of the Immune System | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.12.1002 | HIV Viral Load | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.12.1003 | HIV | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.120.12.1007 | Severe Combined Immunodeficiency | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1200 | Lower Extremity Neurological Tests | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1201 | Lower Extremity Visual Inspection Result or Finding | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1202 | Lower Extremity Visual Inspection Test | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1203 | Monofilament Test Result or Finding | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1204 | Monofilament Tests | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1205 | Pedal Pulse Result or Finding | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1206 | Peripheral Neuropathy | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1207 | Peripheral Neuropathy | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1208 | Peripheral Neuropathy | active | 2023-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1209 | Amputation of Bilateral Feet | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.11.1011 | Consultant Report | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.11.1028 | BMI percentile | active | 2017-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.11.1030 | Height | active | 2019-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.11.1031 | Weight | active | 2017-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.12.1006 | Consultant Report | active | 2024-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.12.1012 | BMI percentile | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.12.1014 | Height | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.121.12.1015 | Weight | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1210 | Amputation of Bilateral Feet | active | 2023-07 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1211 | Amputation of Bilateral Feet | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1212 | Amputation of Left Foot | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1213 | Amputation of Left Foot | active | 2023-07 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1214 | Amputation of Left Foot | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1215 | Amputation of Right Foot | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1216 | Amputation of Right Foot | active | 2023-07 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1217 | Amputation of Right Foot | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1218 | Amputation of Unspecified Foot | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1219 | Amputation of Unspecified Foot | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.122.11.1003 | Ambulatory | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.122.12.1003 | Ambulatory | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1220 | Foot Assessment With Abnormal Result or Finding | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1221 | Foot Assessment With Abnormal Result or Finding | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1222 | Acquired Absence of Bilateral feet | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1223 | Acquired Absence of Bilateral feet | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1224 | Acquired Absence of Left Foot | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1225 | Acquired Absence of Left Foot | active | 2023-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1226 | Acquired Absence of Left Foot | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1227 | Acquired Absence of Right Foot | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1228 | Acquired Absence of Right Foot | active | 2023-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1229 | Acquired Absence of Right Foot | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1230 | Lower Body Fractures Excluding Ankle and Foot | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1231 | Malignant Neoplasms of Lower and Unspecified Limbs | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1232 | Mechanical Complications Excluding Upper Body | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1233 | Partial Arthroplasty of Hip | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1234 | Partial Arthroplasty of Hip | active | 2023-07 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1235 | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1236 | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | 2023-07 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1237 | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | 2023-07 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1238 | Primary THA Procedure | active | 2023-07 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1239 | Foot Ulcer | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1240 | Foot Ulcer | active | 2023-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1241 | Foot Ulcer | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1242 | Referral for Foot Care | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1243 | Therapeutic Footwear | active | 2023-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1244 | Foot Deformity | active | 2023-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1245 | Foot Deformity | active | 2023-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1246 | Foot Deformity | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1247 | Megestrol Medications | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1248 | Meperidine Medications | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1249 | Potentially Harmful Antidepressants for Older Adults | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.11.1004 | Fluoride Varnish Application for Children | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.11.1007 | Dental Caries | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.11.1009 | Dental Caries | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.11.1010 | Clinical Oral Evaluation | active | 2017-05 | us | hl7 | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.11.1011 | Fluoride Varnish Application for Children | active | 2024-02 | us | hl7 | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.12.1002 | Fluoride Varnish Application for Children | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.12.1003 | Clinical Oral Evaluation | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.125.12.1004 | Dental Caries | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1250 | Potentially Harmful Antihistamines for Older Adults | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1251 | Potentially Harmful Antiparkinsonian Agents for Older Adults | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1252 | Potentially Harmful Barbiturates for Older Adults | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1253 | Potentially Harmful Estrogens for Older Adults | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1254 | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1255 | Potentially Harmful Pain Medications for Older Adults | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1256 | Potentially Harmful Skeletal Muscle Relaxants for Older Adults | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1257 | Potentially Harmful Sulfonylureas for Older Adults | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1258 | Substance Use Disorder Long Acting Medication | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1259 | Substance Use Disorder Short Acting Medication | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1260 | Viloxazine | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1266 | Diabetic Retinopathy Severity Level | active | 2025-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1272 | Diabetes | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1273 | Diabetes | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.195.11.1003 | Counseling for Nutrition | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.195.11.1004 | Counseling for Nutrition | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.195.12.1003 | Counseling for Nutrition | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1001 | Antibiotic Medications for Pharyngitis | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1078 | Nifedipine Medications | active | 2022-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1080 | Contraceptive Medications | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1109 | Meperidine Medications | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1129 | Desiccated Thyroid Medications | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1143 | Isotretinoin | active | 2022-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1167 | Dipyridamole Medications | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1205 | Leucovorin | active | 2023-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1211 | Aspirin and Other Antiplatelets | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1212 | DTaP Vaccine | active | 2024-11 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1214 | Hepatitis A Vaccine | active | 2018-03 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1216 | Hepatitis B Vaccine | active | 2025-04 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1220 | Child Influenza Vaccine | active | 2022-02 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1222 | Inactivated Polio Vaccine (IPV) | active | 2021-09 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1228 | Pneumococcal Conjugate Vaccine | active | 2023-11 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1232 | Rotavirus Vaccine (3 dose schedule) | active | 2018-03 | us | hl7 | cvx |